A Review of Studies of the Association of Vision-Related Quality of Life with Measures of Visual Function and Structure in Patients with Glaucoma in the United States

References

• Quigley HA. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–267. doi:10.1136/bjo.2005.081224.
   PubMed Web of Science ®Google Scholar
• Khachatryan N, Bowd C, Medeiros FA, Zangwill LM Optic disc imaging. In: Glaucoma. Second ed. Elsevier Limited; 2014:221–243.
   Google Scholar
• Kapetanakis VV, Chan MPY, Foster PJ, Cook DG, Owen CG, Rudnicka AR. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): A systematic review and meta-analysis. Br J Ophthalmol. 2016;100(1):86–93. doi:10.1136/bjophthalmol-2015-307223.
   PubMed Web of Science ®Google Scholar
• Broman AT, Munoz B, Rodriguez J, et al. The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest Ophthalmol Vis Sci. 2002;43(11):3393–3398.
   PubMed Web of Science ®Google Scholar
• McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R. Impact of visual field loss on health-related quality of life in glaucoma: the los angeles latino eye study. Ophthalmology. 2008;115(6):941–948.e1. doi:10.1016/j.ophtha.2007.08.037.
   PubMed Web of Science ®Google Scholar
• Freeman EE, Munoz B, West SK, Jampel HD, Friedman DS. Glaucoma and quality of life: the salisbury eye evaluation. Ophthalmology. 2008;115(2):233–238. doi:10.1016/j.ophtha.2007.04.050.
   PubMed Web of Science ®Google Scholar
• Ivers RQ, Mitchell P, Cumming RG. Visual function tests, eye disease and symptoms of visual disability: A population-based assessment. Clin Exp Ophthalmol. 2000;28(1):41–47. doi:10.1046/j.1442-9071.2000.00236.x.
   PubMed Web of Science ®Google Scholar
• Mills RP, Janz NK, Wren PA, Guire KE. Correlation of visual field with quality-of-life measures at diagnosis in the collaborative initial glaucoma treatment study (CIGTS). J Glaucoma. 2001;10(3):192–198. 3): 192-198. 10.1097/00061198-200106000-00008.
   PubMed Web of Science ®Google Scholar
• Hahn EA, Cella D, Chassany O, Fairclough DL, Wong GY, Hays RD. Precision of health-related quality-of-life data compared with other clinical measures. Mayo Clin Proc. 2007;82(10):1244–1254. doi:10.4065/82.10.1244.
   PubMed Web of Science ®Google Scholar
• Idler EL, Benyamini Y. Self-rated health and mortality: A review of twenty-seven community studies. J Health Soc Behav. 1997;38(1):21–37. doi:10.2307/2955359.
   PubMed Web of Science ®Google Scholar
• Farkas J, Nabb S, Zaletel-Kragelj L, Cleland JGF, Lainscak M. Self-rated health and mortality in patients with chronic heart failure. Eur J Heart Fail. 2009;11(5):518–524. doi:10.1093/eurjhf/hfp038.
   PubMed Web of Science ®Google Scholar
• Mathews WC, May MS. EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates in HIV-infected adults under care. Health Qual Life Outcomes. 2007;5(1):5. doi:10.1186/1477-7525-5-5.
   PubMedGoogle Scholar
• Haymes SA, LeBlanc RP, Nicolela MT, Chiasson LA, Chauhan BC. Glaucoma and on-road driving performance. Invest Ophthalmol Vis Sci. 2008;49(7):3035–3041. doi:10.1167/iovs.07-1609.
   PubMed Web of Science ®Google Scholar
• Ramulu P. Glaucoma and disability: which tasks are affected, and at what stage of disease? Curr Opin Ophthalmol. 2009;20(2):92–98. doi:10.1097/ICU.0b013e32832401a9.
   PubMed Web of Science ®Google Scholar
• Ramulu PY. Glaucoma and reading speed: the salisbury eye evaluation project. Arch Ophthalmol. 2009;127(1):82–87. doi:10.1001/archophthalmol.2008.523.
   PubMedGoogle Scholar
• Owsley C, McGwin G. Vision and driving. Vision Res. 2010;50(23):2348–2361. doi:10.1016/j.visres.2010.05.021.
   PubMed Web of Science ®Google Scholar
• Haymes SA, Leblanc RP, Nicolela MT, Chiasson LA, Chauhan BC. Risk of falls and motor vehicle collisions in glaucoma. Invest Ophthalmol Vis Sci. 2007;48(3):1149–1155. doi:10.1167/iovs.06-0886.
   PubMed Web of Science ®Google Scholar
• Goldberg I, Clement CI, Chiang TH, et al. Assessing quality of life in patients with glaucoma using the glaucoma quality of life-15 (GQL-15) questionnaire. J Glaucoma. 2009;18(1):6–12.doi:10.1097/IJG.0b013e3181752c83.
   PubMed Web of Science ®Google Scholar
• Nelson P, Aspinall P, Papasouliotis O, Worton B, O’Brien C. Quality of life in glaucoma and its relationship with visual function. J Glaucoma. 2003;12(2):139–150. doi:10.1097/00061198-200304000-00009.
   PubMed Web of Science ®Google Scholar
• Nelson P, Aspinall P, O’Brien C. Patients‘ perception of visual impairment in glaucoma: a pilot study. Br J Ophthalmol. 1999;83(5):546–552. doi:10.1136/bjo.83.5.546.
   PubMed Web of Science ®Google Scholar
• Iester M, Zingirian M. Quality of life in patients with early, moderate and advanced glaucoma. Eye. 2002;16(1):44–49. doi:10.1038/sj.eye.6700036.
   PubMed Web of Science ®Google Scholar
• Janz NK, Wren PA, Lichter PR, Musch DC, Gillespie BW, Guire KE, Mills RP, CIGTS Study Group. The collaborative initial glaucoma treatment study interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology. 2001;108(11):1954–1965.doi:10.1016/S0161-6420(01)00874-0.
   PubMed Web of Science ®Google Scholar
• Javitt J, Goldberg I. Comparison of the clinical success rates and quality of life effects of brimonidine tartrate 0.2% and betaxolol 0.25% suspension in patients with open-angle glaucoma and ocular hypertension. brimonidine outcomes study group II. J Glaucoma. 2000;9(5):398–408. doi:10.1097/00061198-200010000-00009.
   PubMed Web of Science ®Google Scholar
• Nah YS, Seong GJ, Kim CY. Visual function and quality of life in korean patients with glaucoma. Korean J Ophthalmol. 2002;16(2):70–74. doi:10.3341/kjo.2002.16.2.70.
   PubMedGoogle Scholar
• Parrish RK, Gedde SJ, Scott IU, Feuer WJ, Schiffman JC, Mangione CM, Montenegro-Piniella A. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997;115(11):1447–1455.doi:10.1001/archopht.1997.01100160617016.
   PubMedGoogle Scholar
• Lee BL, Gutierrez P, Gordon M, Wilson MR, Cioffi GA, Ritch R, Sherwood M, Mangione CM.The glaucoma symptom scale: A brief index of glaucoma-specific symptoms. Arch Ophthalmol. 1998;116(7):861–866.doi:10.1001/archopht.116.7.861.
   PubMedGoogle Scholar
• Janz NK, Wren PA, Lichter PR, Musch DC, Gillespie BW, Guire KE. Quality of life in newly diagnosed glaucoma patients: the collaborative initial glaucoma treatment study. Ophthalmology. 2001;108(5):887–897. doi:10.1016/S0161-6420(00)00624-2.
   PubMed Web of Science ®Google Scholar
• Walt JG, Rendas-Baum R, Kosinski M, Patel V. Psychometric evaluation of the glaucoma symptom identifier. J Glaucoma. 2011;20(3):148–159. doi:10.1097/IJG.0b013e3181e07970.
   PubMed Web of Science ®Google Scholar
• Peters D, Heijl A, Brenner L, Bengtsson B. Visual impairment and vision-related quality of life in the early manifest glaucoma trial after 20 years of follow-up. Acta Ophthalmol. 2015;93(8):745–752. doi:10.1111/aos.12839.
   PubMed Web of Science ®Google Scholar
• Medeiros FA, Gracitelli CPB, Boer ER, Weinreb RN, Zangwill LM, Rosen PN. Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients. Ophthalmology. 2015;122(2):293–301. doi:10.1016/j.ophtha.2014.08.014.
   PubMed Web of Science ®Google Scholar
• Waisbourd M, Parker S, Ekici F, et al. A prospective, longitudinal, observational cohort study examining how glaucoma affects quality of life and visually-related function over 4 years: design and methodology. BMC Ophthalmol. 2015;15(1):91.doi:10.1186/s12886-015-0088-x.
   PubMedGoogle Scholar
• Mangione CM. Development of the 25-list-item national eye institute visual function questionnaire. Arch Ophthalmol. 2001;119(7):1050–1058. doi:10.1001/archopht.119.7.1050.
   PubMed Web of Science ®Google Scholar
• Mangione CM. Psychometric properties of the national eye institute visual function questionnaire (NEI-VFQ). NEI-VFQ field test investigators. Arch Ophthalmol. 1998;116(11):1496–1504. doi:10.1001/archopht.116.11.1496.
   PubMed Web of Science ®Google Scholar
• Hyman LG, Komaroff E, Heijl A, Bengtsson B, Leske MC. Treatment and vision-related quality of life in the early manifest glaucoma trial. Ophthalmology. 2005;112(9):1505–1513. doi:10.1016/j.ophtha.2005.03.028.
   PubMed Web of Science ®Google Scholar
• Floriani I, Quaranta L, Rulli E, et al. Health-related quality of life in patients with primary open-angle glaucoma. an italian multicentre observational study. Acta Ophthalmol. 2016;94(5):e278.doi:10.1111/aos.12890.
   PubMed Web of Science ®Google Scholar
• Prager AJ, Hood DC, Liebmann JM, et al. Association of glaucoma-related, optical coherence tomography–measured macular damage with vision-related quality of life. JAMA Ophthalmol. 2017;135(7):783–788.doi:10.1001/jamaophthalmol.2017.1659.
   PubMed Web of Science ®Google Scholar
• Garg A, Hood DC, Pensec N, Liebmann JM, Blumberg DM. Macular damage, as determined by structure-function staging, is associated with worse vision-related quality of life in early glaucoma. Am J Ophthalmol. 2018;194:88–94. doi:10.1016/j.ajo.2018.07.011.
   PubMed Web of Science ®Google Scholar
• Ekici F, Loh R, Waisbourd M, et al. Relationships between measures of the ability to perform vision-related activities, vision-related quality of life, and clinical findings in patients with glaucoma. JAMA Ophthalmol. 2015;133(12):1377–1385.doi:10.1001/jamaophthalmol.2015.3426.
   PubMed Web of Science ®Google Scholar
• Abe RY, Diniz-Filho A, Costa VP, Gracitelli CPB, Baig S, Medeiros FA. The impact of location of progressive visual field loss on longitudinal changes in quality of life of patients with glaucoma. Ophthalmology. 2016;123(3):552–557. doi:10.1016/j.ophtha.2015.10.046.
   PubMed Web of Science ®Google Scholar
• Abe RY, Gracitelli CPB, Diniz-Filho A, Zangwill LM, Weinreb RN, Medeiros FA. Frequency doubling technology perimetry and changes in quality of life of glaucoma patients: A longitudinal study. Am J Ophthalmol. 2015;160(1):114–122.e111. doi:10.1016/j.ajo.2015.04.007.
   PubMed Web of Science ®Google Scholar
• Gracitelli CPB, Abe RY, Tatham AJ, et al. Association between progressive retinal nerve fiber layer loss and longitudinal change in quality of life in glaucoma. JAMA Ophthalmol. 2015;133(4):384–390.doi:10.1001/jamaophthalmol.2014.5319.
   PubMed Web of Science ®Google Scholar
• Sun Y, Lin C, Waisbourd M. et al. The impact of visual field clusters on performance-based measures and vision-related quality of life in patients with glaucoma. Am J Ophthalmol. 2016;163:45–52. doi:10.1016/j.ajo.2015.12.006.
   PubMed Web of Science ®Google Scholar
• Daga FB, Gracitelli CPB, Diniz-Filho A, Medeiros FA. Is vision-related quality of life impaired in patients with preperimetric glaucoma? Br J Ophthalmol. 2019;103(7):955–959. doi:10.1136/bjophthalmol-2018-312357.
   PubMed Web of Science ®Google Scholar
• Chun YS, Lee DI, Kwon J, Park IK. Comparison of impact of monocular and integrated binocular visual fields on vision-related quality of life. J Glaucoma. 2017;26(3):283–291. doi:10.1097/IJG.0000000000000623.
   PubMed Web of Science ®Google Scholar
• Jampel HD, Friedman DS, Quigley H, Miller R. Correlation of the binocular visual field with patient assessment of vision. Invest Ophthalmol Vis Sci. 2002;143(4):1059–1067.
   Google Scholar
• Qiu M, Wang SY, Singh K, Lin SC. Association between visual field defects and quality of life in the United States. Ophthalmology. 2014;121(3):733–740. doi:10.1016/j.ophtha.2013.09.043.
   PubMed Web of Science ®Google Scholar
• McKean-Cowdin R, Varma R, Wu J, Hays RD, Azen SP. Severity of visual field loss and health-related quality of life. Am J Ophthalmol. 2007;143(6):1013–1023. doi:10.1016/j.ajo.2007.02.022.
   PubMed Web of Science ®Google Scholar
• Gutierrez P, Wilson MR, Johnson C, Gordon M, Cioffi GA, Ritch R, Sherwood M, Meng K, Mangione CM. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol. 1997;115(6):777–784.doi:10.1001/archopht.1997.01100150779014.
   PubMed Web of Science ®Google Scholar
• Ringsdorf L, McGwin G, Owsley C. Visual field defects and vision-specific health-related quality of life in african americans and whites with glaucoma. J Glaucoma. 2006;15(5):414–418. doi:10.1097/01.ijg.0000212252.72207.c2.
   PubMed Web of Science ®Google Scholar
• Wren PA, Musch DC, Janz NK, Niziol LM, Guire KE, Gillespie BW. Contrasting the use of 2 vision-specific quality of life questionnaires in subjects with open-angle glaucoma. J Glaucoma. 2009;18(5):403–411. doi:10.1097/IJG.0b013e3181879e63.
   PubMed Web of Science ®Google Scholar
• Richman J, Lorenzana LL, Lankaranian D, Dugar J, Mayer J, Wizov SS, Spaeth GL Importance of visual acuity and contrast sensitivity in patients with glaucoma. Arch Ophthalmol. 2010;128(12):1576–1582.doi:10.1001/archophthalmol.2010.275.
   PubMedGoogle Scholar
• Blumberg DM, De Moraes CG, Prager AJ, et al. Association between undetected 10-2 visual field damage and vision-related quality of life in patients with glaucoma. JAMA Ophthalmol. 2017;135(7):742–747.doi:10.1001/jamaophthalmol.2017.1396.
   PubMed Web of Science ®Google Scholar
• Lisboa R, Chun YS, Zangwill LM, et al. Association between rates of binocular visual field loss and vision-related quality of life in patients with glaucoma. JAMA Ophthalmol. 2013;131(4):486–494.doi:10.1001/jamaophthalmol.2013.2602.
   PubMed Web of Science ®Google Scholar
• Jampel HD, Friedman DS, Quigley H, Miller R. Correlation of the binocular visual field with patient assessment of vision. Invest Ophthalmol Vis Sci. 2002;43:1059–1067.
   PubMed Web of Science ®Google Scholar
• Andrich D. Rating scales and Rasch measurement. Expert Rev Pharmacoecon Outcomes Res. 2011;11(5):571–585. doi:10.1586/erp.11.59.
   PubMed Web of Science ®Google Scholar
• Freeman EE, Munoz B, Turano KA, West SK. Measures of visual function and their association with driving modification in older adults. Invest Ophthalmol Vis Sci. 2006;47(2):514–520. doi:10.1167/iovs.05-0934.
   PubMed Web of Science ®Google Scholar
• Lee PP, Cunningham WE, Nakazono TT, Hays RD. Associations of eye diseases and symptoms with self-reported physical and mental health. Am J Ophthalmol. 2009;148(5):804–808.e1. doi:10.1016/j.ajo.2009.06.021.
   PubMed Web of Science ®Google Scholar
• Cheng HC, Guo CY, Chen MJ, Ko YC, Huang N, Liu CJ. Patient-reported vision-related quality of life differences between superior and inferior hemifield visual field defects in primary open-angle glaucoma. JAMA Ophthalmol. 2015;133(3):269–275. doi:10.1001/jamaophthalmol.2014.4908.
   PubMed Web of Science ®Google Scholar
• Black AA, Wood JM, Lovie-Kitchin JE. Inferior field loss increases rate of falls in older adults with glaucoma. Optom Vis Sci. 2011;88(11):1275–1282. doi:10.1097/OPX.0b013e31822f4d6a.
   PubMed Web of Science ®Google Scholar
• Turano KA, Broman AT, Bandeen-Roche K, Munoz B, Rubin GS, West SK. Association of visual field loss and mobility performance in older adults: salisbury eye evaluation study. Optom Vis Sci. 2004;81(5):298–307. doi:10.1097/01.opx.0000134903.13651.8e.
   PubMed Web of Science ®Google Scholar
• Murata H, Hirasawa H, Aoyama Y, et al. Identifying areas of the visual field important for quality of life in patients with glaucoma. PLoS One. 2013;8(3):e58695.doi:10.1371/journal.pone.0058695.
   PubMed Web of Science ®Google Scholar
• Hood DC, Raza AS, De Moraes CG, Liebmann JM, Ritch R. Glaucomatous damage of the macula. Prog Retin Eye Res. 2013;32:1–21. doi:10.1016/j.preteyeres.2012.08.003.
   PubMed Web of Science ®Google Scholar
• Khadka J, Pesudovs K, McAlinden C, Vogel M, Kernt M, Hirneiss C. Reengineering the glaucoma quality of life-15 questionnaire with Rasch analysis. Invest Ophthalmol Vis Sci. 2011;52(9):6971–6977. doi:10.1167/iovs.11-7423.
   PubMed Web of Science ®Google Scholar
• Vandenbroeck S, De Geest S, Zeyen T, Stalmans I, Dobbels F. Patient-reported outcomes (PRO’s) in glaucoma: a systematic review. Eye. 2011;25(5):555–577. doi:10.1038/eye.2011.45.
   PubMed Web of Science ®Google Scholar